Brief: Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-310 for Oral Lichen Planus
20/10/2023 13:03
Oct 20 (Reuters) - Lipella Pharmaceuticals Inc LIPO.O :
* LIPELLA PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND FOR
LP-310 FOR ORAL LICHEN PLANUS
Source text for Eikon: ID:nPn9F1qnQa
Further company coverage: LIPO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipella Pharmaceuticals
See all newsBrief: Lipella Pharmaceuticals Says Bankruptcy Court Approves Sale And Asset Purchase Agreement On June 4
Brief: Lipella Pharmaceuticals Inc. Files Voluntary Petitions For Relief Under Chapter 11
Brief: Lipella Pharmaceuticals Announces Positive Final Results From Phase 2a Study Of LP-10 In Oral Lichen Planus
Brief: Lipella Pharmaceuticals Announces Delisting From Nasdaq Capital Market
U.S. STOCKS ON THE MOVE-Marriott International, Coty, Carlyle Group